期刊
CLINICAL AND TRANSLATIONAL MEDICINE
卷 3, 期 -, 页码 -出版社
SPRINGEROPEN
DOI: 10.1186/2001-1326-3-15
关键词
Induced pluripotent stem cells; Embryonic stem cells; Differentiation and characterization; Lung stem/progenitor cells; Lung tissue engineering
资金
- U.S. Public Health Service National Institutes Health [R21 HL102833-01]
- University Texas Medical School Bridging Grant Program
- Welch Foundation Endowment Fund [7712]
Lung possesses very limited regenerative capacity. Failure to maintain homeostasis of lung epithelial cell populations has been implicated in the development of many life-threatening pulmonary diseases leading to substantial morbidity and mortality worldwide, and currently there is no known cure for these end-stage pulmonary diseases. Embryonic stem cells (ESCs) and somatic cell-derived induced pluripotent stem cells (iPSCs) possess unlimited self-renewal capacity and great potential to differentiate to various cell types of three embryonic germ layers (ectodermal, mesodermal, and endodermal). Therapeutic use of human ESC/iPSC-derived lung progenitor cells for regeneration of injured or diseased lungs will have an enormous clinical impact. This article provides an overview of recent advances in research on pluripotent stem cells in lung tissue regeneration and discusses technical challenges that must be overcome for their clinical applications in the future.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据